Search research articles
Contact Us
Filters
Showing results (201-210 of 235) with videos related to
Page
of 24
Sort By:
Cell Death & Disease
|
December 8, 2025
Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting
Omayma Al-Radi, Katrine Ingelshed, Lisa Eichhorn, et al.
Pharmaceutical Research
|
April 6, 2021
Correction to: Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides
Tanvi J Desai, Bahanu Habulihaz, Joseph R Cannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202
Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Pharmaceutical Research
|
March 16, 2021
Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides
Tanvi J Desai, Bahanu Habulihaz, Joe R Cannon, et al.
Chemical Science
|
July 19, 2019
Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
Tsz Ying Yuen, Christopher J Brown, Yuezhen Xue, et al.
Nature Cell Biology
|
August 25, 2009
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence
Kaori Fujita, Abdul M Mondal, Izumi Horikawa, et al.
The Journal of Physical Chemistry Letters
|
August 18, 2016
Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design
Yaw Sing Tan, Judith Reeks, Christopher J Brown, et al.
Cancer Cell
|
May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
JCI Insight
|
February 23, 2021
Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells
Joanna S Kritikou, Mariana Ms Oliveira, Julien Record, et al.
Cancer Research Communications
|
March 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates Radiotherapy
Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 235) with videos related to
Sort By:
Page
of 24
Cell Death & Disease
|
December 8, 2025
Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting
Omayma Al-Radi, Katrine Ingelshed, Lisa Eichhorn, et al.
Pharmaceutical Research
|
April 6, 2021
Correction to: Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides
Tanvi J Desai, Bahanu Habulihaz, Joseph R Cannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202
Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Pharmaceutical Research
|
March 16, 2021
Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides
Tanvi J Desai, Bahanu Habulihaz, Joe R Cannon, et al.
Chemical Science
|
July 19, 2019
Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
Tsz Ying Yuen, Christopher J Brown, Yuezhen Xue, et al.
Nature Cell Biology
|
August 25, 2009
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence
Kaori Fujita, Abdul M Mondal, Izumi Horikawa, et al.
The Journal of Physical Chemistry Letters
|
August 18, 2016
Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design
Yaw Sing Tan, Judith Reeks, Christopher J Brown, et al.
Cancer Cell
|
May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
JCI Insight
|
February 23, 2021
Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells
Joanna S Kritikou, Mariana Ms Oliveira, Julien Record, et al.
Cancer Research Communications
|
March 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates Radiotherapy
Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan, et al.
Page
of 24